glutathione s-transferase class-mu 26 kda isozyme Overexpression of S-Transferases in Human Diseases: Drug Targets and Therapeutic Implications Frontiers | Glutathione S-Transferase P1
Description
& Bataller, R
10.3390/jcm13175088 55
Situations where oral administration is not feasible (e.g., anorexia, nausea, pre-op, GI absorption issues)
Bouchard, C., Marquardt, J., Brs, A., Medema, R
Mild injection-site reactions affect approximately 5-10 percent of recipients, while systemic effects are less frequent but warrant careful monitoring
The mechanisms underlying the specific effect on infarct volume remain to be identified, but one possibility is that the protection is mediated through increased astroglial activation in the border zone of the infarct 569
